[老年人多病性心力衰竭]
Katharina Schmidt-Mende1, Karin Modig2
1med dr, docent och specialist i allmänmedicin, Akademiskt primärvårds-centrum; Karolinska -institute.
概括
本案例研究强调了标准心力衰竭 (HF) 准则如何在患有多种疾病的老年患者中引起不良事件. 仔细的药物审查和剂量调整对于管理复杂的患者护理至关重要.
科学领域:
- 老年病的医生 老年病的医生
- 内部医学 内部医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 老年患者经常出现多种并发症,使治疗复杂化.
- 标准治疗指南可能无法充分满足多病症老年人的需求.
- 在这个人群中,不良药物事件很常见,导致显著的发病率.
研究的目的:
- 描述一位患有心力衰竭 (HF) 和多病症的老年患者的案例研究.
- 为了说明在复杂患者中严格遵守HF指南的潜在不良影响.
- 强调需要个性化治疗和指导方针的适应在老年护理.
主要方法:
- 一个案例研究方法专注于一个90岁的女性患者心力衰竭和心房动.
- 临床监测药物效应,包括认知功能 (时钟绘图测试),功能和血压.
- 药物停用或剂量减少后治疗结果的分析.
主要成果:
- 遵守高压指南导致过渡性混乱,功能衰竭和低血压.
- 在调整药物治疗方案后,认知障碍得到解决.
- 患者在日常生活中经历了依赖和计划外住院.
结论:
- 单一疾病的指导方针在具有多种疾病的老年人中适用性有限.
- 密切监测副作用和临床判断是必不可少的,有时需要偏离指南.
- 一般医生在制定老年人特定治疗指南方面发挥着至关重要的作用.
相关概念视频
Heart Failure II: Pathophysiology
768
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
768
Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Heart Failure I: Introduction
720
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
720
Heart Failure VI: Adjunct Therapies
273
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
273
Heart Failure Drugs: Diuretics
821
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
821
Heart Failure V: Medical Management
225
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
225


